< Back to search
Filter
1

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed Multiple Myeloma, Refractory Multiple Myeloma
Location: Boston MA, Rochester NY, Chapel Hill NC, Detroit MI,
Sponsor: Opna Bio LLC

Sex: All

Age: 18+

Code: NCT06433947

Phase1, Recruiting

Hypofractionation (Radiation) Trial for Multiple Myeloma

for
Multiple Myeloma
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06270888

Phase1, Recruiting

Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab

for
Multiple Myeloma, Refractory Multiple Myeloma
Location: Seattle WA
Sponsor: Pack Health

Sex: All

Age: 18+

Code: NCT05053607

Recruiting

Mosaic Trial for Stem Cell Transplant Recipients

for
Hematologic Malignancy, Stem Cell Transplant,
Location: Nutley NJ, Washington D.C. DC, Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06960993

Recruiting

Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance

for
Multiple Myeloma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06483100

Phase2, Recruiting

Interested in new multiple myeloma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

for
NHL, Multiple Myeloma, Blood Cancer,
Location: Providence RI, Fairfax VA, Winston-Salem NC,
Sponsor: Indapta Therapeutics, INC.

Sex: All

Age: 18+

Code: NCT06119685

Phase1, Phase2, Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: Boston MA, Shirley NY, Farmington CT, Lake Success NY,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase3, Recruiting

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

for
Multiple Myeloma
Location: Moncton, Boston MA, Providence RI, Lake Success NY,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06152575

Phase3, Recruiting

Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma

for
Multiple Myeloma, Relapse Multiple Myeloma
Location: Boston MA, Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT05789303

Phase2, Recruiting

Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)

for
Multiple Myeloma, Amyloidosis
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT04991103

Phase2, Recruiting

Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma

for
Multiple Myeloma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT06207799

Phase2, Recruiting

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions

for
Multiple Myeloma, Smoldering Multiple Myeloma,
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT05361694

Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

for
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors
Location: Augusta ME, Brewer ME, Rockport ME, Belfast ME,
Sponsor: American Society of Clinical Oncology

Sex: All

Age: 12+

Code: NCT02693535

Phase2, Recruiting

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

for
Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT06784167

Recruiting

A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

for
Multiple Myeloma
Location: West Reading PA, Bethesda MD, Delray Beach FL,
Sponsor: Stichting European Myeloma Network

Sex: All

Age: 18+

Code: NCT05028348

Phase3, Recruiting

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

for
Smoldering Multiple Myeloma
Location: Boston MA, New York NY, Richmond VA, Durham NC,
Sponsor: Tufts Medical Center

Sex: All

Age: 40+

Code: NCT06365060

Recruiting

MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

for
Multiple Myeloma, Smoldering Multiple Myeloma,
Location: Lehi UT
Sponsor: HealthTree Foundation

Sex: All

Age: 18+

Code: NCT04727294

Recruiting

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

for
Multiple Myeloma, Hypogammaglobulinemia,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06976476

Phase2, Recruiting

Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor

for
Multiple Myeloma, Lymphoma, Acute Myelogenous Leukemia,
Location: Denver CO
Sponsor: Colorado Blood Cancer Institute

Sex: All

Age: 50 - 70

Code: NCT00304720

Phase2, Recruiting

Neurologic Stem Cell Treatment Study

for
Neurologic Disorders, Nervous System Diseases,
Location: Westport CT, Coral Springs FL
Sponsor: MD Stem Cells

Sex: All

Age: 18+

Code: NCT02795052

Recruiting